» Articles » PMID: 39150225

Lessons on the Use of Real-world Data in Medical Device Research: Findings from the National Evaluation System for Health Technology Test-Cases

Overview
Journal J Comp Eff Res
Specialty Health Services
Date 2024 Aug 16
PMID 39150225
Authors
Affiliations
Soon will be listed here.
Abstract

Although the US FDA encourages manufacturers of medical devices to submit real-world evidence (RWE) to support regulatory decisions, the ability of real-world data (RWD) to generate evidence suitable for decision making remains unclear. The 2017 Medical Device User Fee Amendments (MDUFA IV), authorized the National Evaluation System for health Technology Coordinating Center (NESTcc) to conduct pilot projects, or 'Test-Cases', to assess whether current RWD captures the information needed to answer research questions proposed by industry stakeholders. We synthesized key lessons about the challenges conducting research with RWD and the strategies used by research teams to enhance their ability to generate evidence from RWD based on 18 Test-Cases conducted between 2020 and 2022. We reviewed study protocols and reports from each Test-Case team and conducted 49 semi-structured interviews with representatives of participating organizations. Interview transcripts were coded and thematically analyzed. Challenges that stakeholders encountered in working with RWD included the lack of unique device identifiers, capturing key data elements and their appropriate meaning in structured data, limited reliability of diagnosis and procedure codes in structured data, extracting information from unstructured electronic health record (EHR) data, limited capture of long-term study end points, missing data and data sharing. Successful strategies included using manufacturer and supply chain data, leveraging clinical registries and registry reporting processes to collect and aggregate data, querying standardized EHR data, implementing natural language processing algorithms and using multidisciplinary research teams. The Test-Cases identified numerous challenges working with RWD but also opportunities to address these challenges and improve researchers' ability to use RWD to generate evidence on medical devices.

Citing Articles

The Healthcare Integrated Research Database (HIRD) as a Real-World Data Source for Pharmacoepidemiologic Research.

Barron J, Willey V, Doherty B, Tunceli O, Waltz C, Grabner M Pharmacoepidemiol Drug Saf. 2025; 34(2):e70110.

PMID: 39909722 PMC: 11798679. DOI: 10.1002/pds.70110.

References
1.
Tcheng J, Nguyen M, Brann H, Clarke P, Pfeiffer M, Pleasants J . The Medical Device Unique Device Identifier as the Single Source of Truth in Healthcare Enterprises - Roadmap for Implementation of the Clinically Integrated Supply Chain. Med Devices (Auckl). 2022; 14:459-467. PMC: 8714004. DOI: 10.2147/MDER.S344132. View

2.
Timbie J, Kim A, Concannon T . Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment. Value Health. 2021; 24(12):1792-1798. DOI: 10.1016/j.jval.2021.07.003. View

3.
Dhruva S, Ridgeway J, Ross J, Drozda Jr J, Wilson N . Exploring unique device identifier implementation and use for real-world evidence: a mixed-methods study with NESTcc health system network collaborators. BMJ Surg Interv Health Technol. 2023; 5(1):e000167. PMC: 9872505. DOI: 10.1136/bmjsit-2022-000167. View

4.
Pappas G, Berlin J, Avila-Tang E, Carroll J, Drozda J, Dumont D . Determining value of Coordinated Registry Networks (CRNs): a case of transcatheter valve therapies. BMJ Surg Interv Health Technol. 2022; 1(1):e000003. PMC: 8749335. DOI: 10.1136/bmjsit-2019-000003. View

5.
Bartlett V, Dhruva S, Shah N, Ryan P, Ross J . Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence. JAMA Netw Open. 2019; 2(10):e1912869. PMC: 6802419. DOI: 10.1001/jamanetworkopen.2019.12869. View